Fatty Acid Oxidation and Ketone Body Metabolism Study Guide

Overview of Fatty Acid Oxidation and Biological Significance

Oxidation of fatty acids serves as a foundational energy source across many biological systems. In terms of human dietary needs, approximately one-third of total energy requirements are met through the consumption of triacylglycerols. This dependence on lipids is even more pronounced in specific mammalian organs; for instance, about $80\%$ of the energy requirements for the mammalian heart and liver are satisfied specifically by the oxidation of fatty acids. Furthermore, fatty acid oxidation is critical for survival in certain ecological contexts; many hibernating animals, such as grizzly bears, rely almost exclusively on stored fats as their primary source of metabolic energy during periods of dormancy.

Digestion, Absorption, and Hydrolysis of Triacylglycerols

The processing of dietary fats begins in the digestive system where triacylglycerols (TAGs) undergo a cycle of degradation and reconstruction. In the intestinal lumen, Triacylglycerides are combined with $H_2O$ and acted upon by enzymes known as lipases. This reaction breaks down triacylglycerols into fatty acids and monoacylglycerols. Once these components pass into the mucosal cell of the intestine, they are remade into triacylglycerides. These reconstructed fats are then packaged with other lipids and proteins into chylomicrons, which are subsequently transported into the lymph system.

The hydrolysis of triacylglycerols is a catalyze-driven process facilitated by lipases. These enzymes are tightly regulated by hormonal signaling based on the body's energy status. Epinephrine acts as a signal indicating that the body requires energy immediately ("We need energy now"), while glucagon serves as a signal that glucose reserves are depleted ("We are out of glucose"). The resulting products of this hydrolysis are fatty acids and glycerol.

Glycerol Metabolism and Glycolysis Entry

Glycerol derived from the hydrolysis of fats can enter the glycolytic pathway to contribute to energy production. This starts with glycerol kinase, which activates glycerol through phosphorylation at the expense of one molecule of $ATP$. Although this requires an initial energy investment, subsequent metabolic reactions recover more than enough $ATP$ to offset this cost. The activated glycerol is then oxidized to become dihydroxyacetone phosphate ($DHAP$), a glycolytic intermediate. This integration allows for a limited capacity for the anaerobic catabolism of fats, as the glycerol backbone enters the glycolytic sequence.

Transport and Classification of Fatty Acids in Blood and Cells

Fatty acid oxidation occurs within the mitochondria, necessitating a transport mechanism from the blood into the cell. In the bloodstream, fatty acids are transported as Free Fatty Acids ($FFA$), which are also referred to as unesterified ($UFA$) or nonesterified ($NEFA$) fatty acids. Specifically, in plasma, longer-chain $FFA$ are bound to albumin for transport. Once inside the cell, longer-chain $FFA$ are attached to specific fatty acid-binding proteins. In contrast, shorter-chain fatty acids exhibit higher water solubility and exist either as unionized acids or as fatty acid anions.

There are three distinct types of fatty acid oxidation: $\alpha$-oxidation, $\beta$-oxidation, and $\omega$-oxidation. Among these, $\beta$-oxidation is the most significant pathway, accounting for approximately $90\%$ of all fatty acid oxidation. This process involves the successive removal of two carbons from the carboxylic end of an active fatty acid (acyl CoA) in the form of acetyl CoA. The metabolic fate of the resulting acetyl CoA depends on the tissue type: in the liver, it is converted into ketone bodies and transported to other tissues for energy utilization, whereas in muscle tissue, it is metabolized directly in the Tricarboxylic Acid ($TCA$) cycle to generate energy.

The Mechanism and Steps of $\beta$-Oxidation

The $\beta$-oxidation pathway is a multi-step sequence that begins with the activation of the fatty acid and concludes with the systematic cleavage of carbon units. The chain is broken specifically between the $\alpha(2)$- and $\beta(3)$-carbon atoms, which provides the pathway with its name.

Step I involves Fatty Acid Activation by esterification with coenzyme A. This activation is required before the fatty acid can be catabolized and necessitates energy from $ATP$. The enzyme acyl-CoA synthetase, also known as thiokinase, catalyzes the conversion of a fatty acid into an "active fatty acid" or acyl-CoA in the presence of Coenzyme A and $ATP$. The summarized reaction is: $\text{Fatty Acid} + \text{Coenzyme A} + ATP \rightarrow \text{Acyl-CoA} + AMP + PPi$

Step II involves the membrane transport of fatty acyl CoA esters. While small fatty acids (fewer than $12$ carbons) can diffuse freely across mitochondrial membranes, larger fatty acids (which comprise most free fatty acids) cannot penetrate the inner mitochondrial membrane. These larger molecules requires a carnitine protein shuttle. The acyl-carnitine/carnitine transporter facilitates the movement of these fatty acids into the mitochondrial matrix.

Step III is the Carbon Backbone Reaction Sequence. This is a recurring four-step process that breaks down the fatty acid into Acetyl coenzyme A (which enters the Krebs Cycle), $FADH_2$, and $NADH$ (both of which enter oxidative phosphorylation to produce $ATP$). The sequence breaks off two carbons at a time as acetyl CoA, and the remaining chain repeats the cycle.

The four specific chemical reactions in the $\beta$-oxidation sequence are:

1. Dehydrogenation: The first step removes two hydrogen atoms from Acyl CoA and requires $FAD$. Using the enzyme Acyl-CoA Dehydrogenase, the starting Fatty Acyl-CoA is converted to $trans-\Delta^2\text{-Enoyl-CoA}$, producing $FADH_2$.

2. Hydration: Water ($H_2O$) is added via the enzyme Enoyl-CoA Hydratase to produce $L\text{-}\beta\text{-Hydroxylacyl-CoA}$.

3. Dehydrogenation: A second removal of two hydrogen atoms occurs, catalyzed by a dehydrogenase enzyme ($L\text{-Hydroxyacyl-CoA Dehydrogenase}$), which requires $NAD^+$ to produce $NADH + H^+$ and $\beta\text{-Ketoacyl-CoA}$.

4. Carbon-Carbon Cleavage (Thiolase Reaction): The $\beta\text{-Ketoacyl-CoA}$ is split by the enzyme thiolase using $CoA\text{-}SH$ to produce one molecule of Acetyl-CoA and a new Fatty Acyl-CoA that is shortened by exactly two carbons.

Energy Yield from Palmitic Acid Oxidation

For a molecule like palmitic acid ($C_{16}$), the $\beta$-oxidation process is highly efficient. To fully oxidize palmitoyl CoA, which has $16$ carbon atoms, it must undergo $7$ cycles of $\beta$-oxidation. This results in the production of $8$ molecules of acetyl-CoA, $7$ molecules of $FADH_2$, and $7$ molecules of $NADH + H^+$. The acetyl-CoA molecules then enter the citric acid cycle for further oxidation into $CO_2$, yielding additional $GTP$, $NADH$, and $FADH_2$. Electrons from all produced $FADH_2$ and $NADH$ enter the Electron Transfer Flavoprotein ($ETF$).

The final energy yield for Palmitic Acid ($C_{16}$) is calculated as follows:

• $7 \text{ rounds of } \beta\text{-oxidation} \times FADH_2 \times 1.5\,ATP = 10.5\,ATP$

• $7 \text{ rounds of } \beta\text{-oxidation} \times NADH \times 2.5\,ATP = 17.5\,ATP$

• $8 \text{ Acetyl CoA entering Krebs cycle:}$

• $8 \times 3\,NADH \times 2.5\,ATP = 60\,ATP$

• $8 \times FADH_2 \times 1.5\,ATP = 12\,ATP$

• $8 \times GTP \times 1\,ATP = 8\,ATP$

• Activation Energy Cost: $-2\,ATP$

• Total Energy Yield: $106\,ATP$

Special Considerations and Metabolism Regulation

Unsaturated fats require additional processing because their double bonds are typically in the cis configuration. Special enzymes are required to convert these cis bonds to trans bonds before they can be successfully oxidized through the standard $\beta$-oxidation pathway.

Fatty acid oxidation is tightly regulated to prevent metabolic conflicts. It is stimulated by the hormones epinephrine and glucagon. Conversely, it is inhibited by Malonyl-CoA, which is an early intermediate in fatty acid synthesis. Malonyl-CoA prevents fatty acids from entering the mitochondria by inhibiting carnitine acyltransferase I, thereby ensuring that fatty acid breakdown does not occur simultaneously with fatty acid synthesis. Additionally, high levels of $NADH$ inhibit the enzyme $\beta\text{-hydroxyacyl CoA Dehydrogenase}$, slowing down the oxidation process.

Formation and Utilization of Ketone Bodies

Ketone bodies are formed in the liver as a backup energy supply when glucose is unavailable. Acetyl-CoA produced during liver fatty acid oxidation can either enter the citric acid cycle or be converted into ketone bodies. These bodies are water-soluble and can be quickly released into the bloodstream to provide energy to other tissues.

The process of ketogenesis begins with a thiolase reaction that joins two acetate units, effectively reversing the last step of $\beta$-oxidation. A third condensation with acetyl-CoA produces $HMG\text{-}CoA$, which is a precursor for cholesterol and isoprenes. $HMG\text{-}CoA$ is then cleaved into free acetoacetate and acetyl-CoA. Acetoacetate, a $\beta\text{-keto}$ acid, is unstable and can spontaneously decarboxylate or be reduced to more stable compounds using $NADH$. For example, in diabetic patients where ketone production is high, volatile acetone can be detected on the breath.

While the liver is the primary source of ketone bodies, it cannot utilize them for energy. Ketone bodies are released into the blood and taken up by extrahepatic organs. $\beta\text{-hydroxybutyrate}$ is oxidized back to acetoacetate, which is then activated by transferring a Coenzyme A group from succinyl-CoA. This reaction is catalyzed by $\beta\text{-ketoacyl-CoA transferase}$, also known as thiophorase. The final step involves cleavage by thiolase to yield two acetyl-CoA molecules for entrance into the Citric Acid Cycle ($CAC$). It is noted that high levels of ketone bodies (acetoacetate and $\beta\text{-hydroxybutyrate}$) can dangerously lower blood pH, leading to a condition known as acidosis, common in starvation and uncontrolled diabetes.